Swedish registers to examine drug safety and clinical issues in RA
(2006) In Annals of the Rheumatic Diseases 65(6). p.707-712- Abstract
- Data from several different monitoring systems are examined. The potential for registers based on data obtained from clinical practice, and linkage of such data to national health and population registers, is discussed. The approach described is a possible prototype for long term surveillance systems needed for the safe introduction of new treatments.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/409829
- author
- Askling, J ; Fored, CM ; Geborek, Pierre LU ; Jacobsson, LTH ; van Vollenhoven, R ; Feltelius, N ; Lindblad, S and Klareskog, L
- organization
- publishing date
- 2006
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Annals of the Rheumatic Diseases
- volume
- 65
- issue
- 6
- pages
- 707 - 712
- publisher
- BMJ Publishing Group
- external identifiers
-
- pmid:16414975
- wos:000237513300003
- scopus:33744457274
- ISSN
- 1468-2060
- DOI
- 10.1136/ard.2005.045872
- language
- English
- LU publication?
- yes
- id
- 6be2e4ac-1cf0-4833-ab4a-bc6517887491 (old id 409829)
- date added to LUP
- 2016-04-01 16:46:39
- date last changed
- 2022-03-30 18:11:02
@article{6be2e4ac-1cf0-4833-ab4a-bc6517887491, abstract = {{Data from several different monitoring systems are examined. The potential for registers based on data obtained from clinical practice, and linkage of such data to national health and population registers, is discussed. The approach described is a possible prototype for long term surveillance systems needed for the safe introduction of new treatments.}}, author = {{Askling, J and Fored, CM and Geborek, Pierre and Jacobsson, LTH and van Vollenhoven, R and Feltelius, N and Lindblad, S and Klareskog, L}}, issn = {{1468-2060}}, language = {{eng}}, number = {{6}}, pages = {{707--712}}, publisher = {{BMJ Publishing Group}}, series = {{Annals of the Rheumatic Diseases}}, title = {{Swedish registers to examine drug safety and clinical issues in RA}}, url = {{http://dx.doi.org/10.1136/ard.2005.045872}}, doi = {{10.1136/ard.2005.045872}}, volume = {{65}}, year = {{2006}}, }